Ibrahim Shatat to Hypertension
This is a "connection" page, showing publications Ibrahim Shatat has written about Hypertension.
Connection Strength
1.531
-
Antihypertensive agents: a long way to safe drug prescribing in children. Pediatr Nephrol. 2020 11; 35(11):2049-2065.
Score: 0.350
-
Gut microbiome and kidney disease: a bidirectional relationship. Pediatr Nephrol. 2017 06; 32(6):921-931.
Score: 0.274
-
The efficacy and safety of intravenous hydralazine for the treatment of hypertension in the hospitalized child. Pediatr Nephrol. 2014 Aug; 29(8):1403-9.
Score: 0.236
-
Blood pressure reclassification in adolescents based on repeat clinic blood pressure measurements. J Clin Hypertens (Greenwich). 2013 Oct; 15(10):717-22.
Score: 0.226
-
Hypertension in children with chronic kidney disease. Adv Chronic Kidney Dis. 2005 Oct; 12(4):378-84.
Score: 0.132
-
Bifidobacterium reduction is associated with high blood pressure in children with type 1 diabetes mellitus. Biomed Pharmacother. 2021 Aug; 140:111736.
Score: 0.097
-
Closing the gap in hypertension control between younger and older adults: National Health and Nutrition Examination Survey (NHANES) 1988 to 2010. Circulation. 2014 May 20; 129(20):2052-61.
Score: 0.059
-
Therapy of acute hypertension in hospitalized children and adolescents. Curr Hypertens Rep. 2014 Apr; 16(4):425.
Score: 0.059
-
Hypertension and obesity: epidemiology, mechanisms and clinical approach. Indian J Pediatr. 2012 Aug; 79(8):1056-61.
Score: 0.052
-
Prevalence and clinical correlates of microalbuminuria in children with sickle cell disease. Pediatr Nephrol. 2010 Aug; 25(8):1505-11.
Score: 0.045